Dr. Peter McCullough | Chemo Risks, Ivermectin Potential, and Tick Bite Dangers

Steve Gruber is joined by Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, to discuss a groundbreaking new study suggesting chemotherapy might reactivate dormant cancer cells, and what that means for patients. They dive into Big Pharma’s reluctance to explore low-cost alternatives, the emerging potential of ivermectin as a cancer treatment, and practical advice for parasite cleansing and protecting against the spike in tick bites this year.

 

Visit twc.health/GRUBER, Promo Code GRUBER Saves 10%.